News

Article

bit.bio featured in European Biopharmaceutical Review

Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.

28.03.2022

Published by EBR

Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.

Published by EBR

Read now

Podcast

bit.bio CEO featured on the Built with Biology podcast

bit.bio CEO Dr Mark Kotter interviewed by Fiona Mischel on the Built with Biology Podcast.

25.03.2022

Published by Synbiobeta

Read now

Podcast

bit.bio CEO featured on the Hightech Ventures podcast

They ask about reprogramming cells and how the company is aiming to develop cell therapies.

17.03.2022

Published by Hightech Ventures

Read now

Article

bit.bio featured in BioSpace

The article offers 6 tips for successful pharma startups.

01.03.2022

Published by BioSpace

Read now

Article

bit.bio featured as case study by Cambridge Judge Business School

This case study delves into the company story, technology and vision.

16.02.2022

Published by Cambridge JBS

Read now

Article

bit.bio featured in TechRound list of top University of Cambridge spin outs

The list looks at how companies are performing and what they are working on.

10.02.2022

Published by TechRound

Read now

Article

bit.bio CEO featured in Technology Networks

Technology Networks cover the development, benefits and applications of ioSkeletal Myocytes.

03.02.2022

Published by Technology Networks

Read now

Article

bit.bio CEO featured in TechRound

Founder and CEO Dr Mark Kotter joined the experts who have given their thoughts on what is to come for the health sector in 2022.

31.01.2022

Published by TechRound

Read now

Article

This Startup Is Making — and Programming — Human Cells

Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.

21.12.2021

Published by Wired

Read now

Related pages